Tanhente, Aires J.
HRN: 18-13-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
BENZYL PENICILLIN 1MU (VIAL)
09/02/2023
09/09/2023
IV
700,000units
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes